Antibodies Boost Photodynamic Therapy’s Efficacy - IDEX Health & ScienceIDEX Health & Science


    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Antibodies Boost Photodynamic Therapy’s Efficacy

    Article obtained from Photonics RSS Feed.

    Adding antibodies to photodynamic therapies can bolster their efficacy, according to research conducted by Texas A&M University and the University of São Paulo. The work reviewed the existing approaches to photodynamic therapies and provided a model to help expedite development of photodynamic therapies as a rapid response to emergent pandemics.

    In photodynamic therapy (PDT), photosensitizers composed of dyes and other light-reacting compounds are typically administered intravenously or are applied topically to the area where treatment is needed; they are then absorbed by microbes or cancer cells. When light is applied, the compounds react, forming reactive oxygen species — toxic oxygen molecules that kill the cancer…

    May, 25 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.